Home / Companies / Coherus BioSciences, Inc. / 11 Jun 2025
Coherus BioSciences, Inc.: meeting of 11 Jun 2025
Votes reported on Form N-PX, item by item
165 Form N-PX filers reported votes at the Coherus BioSciences, Inc. meeting of 11 Jun 2025. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 89.5% of reported votes for; 13 filers withheld from or voted against at least one nominee.
312 vote records from 57 filers. 4 of the 57 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
229 vote records from 164 filers. 104 of the 156 filers that marked the item either way voted against management. 8 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
104 vote records from 57 filers. 2 of the 57 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
6 vote records from 3 filers. 0 of the 3 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
99 vote records from 55 filers. 2 of the 55 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | Against * | For |
| State Street and SPDR | For | For | For |
| Invesco | For | Against * | For |
| Equitable | Abstain or withhold * | Against * | For |
| Charles Schwab | For | Against * | For |
| Nuveen and TIAA | For | Against * | For |
| ProShares and ProFunds | For | Against * | For |
| John Hancock and Manulife | For | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | For | For |
| J.P. Morgan | No report | For | No report |
| Goldman Sachs | For | Against * | For |
| WisdomTree | For | For | For |
| PGIM and Prudential | No report | Against * | No report |
| Northern Trust and FlexShares | For | Against * | For |
| SEI | For | Against * | For |
| T. Rowe Price | For | Against * | For |
| Lincoln Financial | For | For | For |
| Voya | For | Against * | For |
| First Trust | No report | Split or no vote | No report |
| Nationwide | For | For | For |
| Victory Capital | For | Against * | For |
| Guggenheim and Rydex | For | Against * | For |
| Columbia Threadneedle | For | Against * | For |
| BNY Mellon | No report | For | No report |
| Principal | No report | Against * | No report |
| Pacific Life funds | For | For | For |
| Global X | For | Against * | For |
| AllianceBernstein | No report | Against * | No report |
| DWS | For | Against * | For |
| Macquarie and Delaware Funds | For | Against * | For |
| Neuberger Berman | No report | Against * | No report |
| Baird | No report | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Coherus BioSciences, Inc. meeting?
165 Form N-PX filers reported votes at the meeting of 11 Jun 2025. On say-on-pay, 104 of 156 voted against management (66.7%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Coherus BioSciences, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Coherus BioSciences, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Coherus BioSciences, Inc. with a meeting date within three days of 11 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.